06/22/2022
Excited to announce our collaboration with Phibro Animal Health, to develop and commercialize a gene therapy for (MVD) in dogs. View the full release here: https://www.businesswire.com/news/home/20220622005079/en/Phibro-Animal-Health-Corporation-and-Rejuvenate-Bio-Announce-Agreement-to-Develop-Gene-Therapy-for-Mitral-Valve-Disease-in-Canines